Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1

Rhea-AI Summary

Glaukos (NYSE: GKOS) is set to announce its first quarter 2024 financial results on May 1, 2024. The company, known for its innovative therapies in ophthalmology, will host a conference call and webcast to discuss the results.

Conference Call and Webcast Scheduled for 1:30 p.m. PT

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release first quarter 2024 financial results after the market close on Wednesday, May 1, 2024. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PT (4:30 p.m. ET) on May 1, 2024.

A link to the live webcast will be available on the company’s website at http://investors.glaukos.com. To participate in the conference call, please dial 888-210-2212 (U.S.) or 646-960-0390 (International) and enter Conference ID 7935742. A replay will be archived on the company’s website following completion of the call.

About Glaukos

Glaukos (www.glaukos.com) is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012, and continues to develop a portfolio of technologically distinct and leverageable platforms to support ongoing pharmaceutical and medical device innovations. Products or product candidates for each of these platforms are designed to advance the standard of care through better treatment options across the areas of glaucoma, corneal disorders and retinal diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240410647328/en/

Chris Lewis

Vice President, Investor Relations and Corporate Affairs

(949) 481-0510

clewis@glaukos.com

Source: Glaukos Corporation

FAQ

When will Glaukos (GKOS) release its first quarter 2024 financial results?

Glaukos (GKOS) plans to release its first quarter 2024 financial results after the market close on Wednesday, May 1, 2024.

What time is the conference call and webcast scheduled for discussing the financial results?

The conference call and simultaneous webcast to discuss the financial results are scheduled for 1:30 p.m. PT (4:30 p.m. ET) on May 1, 2024.

How can one participate in the conference call?

To participate in the conference call, dial 888-210-2212 (U.S.) or 646-960-0390 (International) and enter Conference ID 7935742.

Where can one find the live webcast of the conference call?

A link to the live webcast will be available on Glaukos 's website at http://investors.glaukos.com.